Zydus’ HIV generic drug ready for market use following approval from the US Food & Drug Administration

INDIA – Zydus Cadila, a drug manufacturing company based in India, has received approval from the US Food & Drug Association(USFDA) to market generic Emtricitabine and Tenofovir Disoproxil Fumarate tablets used for treatment of HIV infection. According to Zydus Cadila, the drugs are to be used alongside other medications to help control HIV infectons to decrease the amount of HIV in one’s body so that the immune system can work better. Manufacturing of the drugs is set to be done in Zydus’ facility based in Ahmedabad, India. HIV as an…

Read More

Gilead files with the US Food and Drug Administration for approval of its HIV drug lenacapavir

US – The American biopharmaceutical company, Gilead Sciences has filed its investigational long -acting HIV therapy, lencapavir with the US Food and Drug Administration (USFDA) for approval as therapy for patients with multi-drug resistant infection. In its submission, Gilead has included data from the Phase II/III CAPELLA trial, which evaluated the safety and efficacy of lenacapavir administered subcutaneously (under the skin) every six months in combination with an optimized antiretroviral background regimen. The FDA has already granted lenacapavir a breakthrough therapy designation for the treatment of HIV-1 infection in this…

Read More